Global Payments To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Thursday
Portfolio Pulse from Lisa Levin
Several analyst forecasts were released on Thursday, with price target changes for i3 Verticals, Arhaus, Wix.com, FLEETCOR Technologies, Viridian Therapeutics, Terns Pharmaceuticals, Deciphera Pharmaceuticals, Global Payments, OneSpan, Nuvei Corporation, and Decibel Therapeutics. The changes included both upgrades and downgrades, with the most significant being a price target cut for Decibel Therapeutics from $21 to $5.25 by Baird.
August 10, 2023 | 11:53 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Telsey Advisory Group increased Arhaus's price target from $13 to $15, maintaining an Outperform rating.
The price target increase by Telsey Advisory Group could lead to a positive sentiment among investors, potentially impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Stifel increased Deciphera Pharmaceuticals's price target from $14 to $20, upgrading the stock from Hold to Buy.
The price target increase and upgrade by Stifel could lead to a positive sentiment among investors, potentially impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Raymond James increased the price target for FLEETCOR Technologies from $246 to $283, maintaining an Outperform rating.
The price target increase by Raymond James could lead to a positive sentiment among investors, potentially impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Jefferies boosted Global Payments's price target from $125 to $145, upgrading the stock from Hold to Buy.
The price target increase and upgrade by Jefferies could lead to a positive sentiment among investors, potentially impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Piper Sandler boosted the price target for Wix.com from $120 to $130, maintaining an Overweight rating.
The price target increase by Piper Sandler could lead to a positive sentiment among investors, potentially impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Baird cut Decibel Therapeutics's price target from $21 to $5.25, downgrading the stock from Outperform to Neutral.
The significant price target cut and downgrade by Baird could lead to a negative sentiment among investors, potentially impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Keybanc cut the price target for i3 Verticals from $28 to $26, maintaining an Overweight rating.
The price target cut by Keybanc could lead to a negative sentiment among investors, potentially impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Goldman Sachs lowered Nuvei Corporation's price target from $41 to $22, downgrading the stock from Buy to Neutral.
The price target cut and downgrade by Goldman Sachs could lead to a negative sentiment among investors, potentially impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
DA Davidson slashed the price target for OneSpan from $19 to $12, downgrading the stock from Buy to Neutral.
The price target cut and downgrade by DA Davidson could lead to a negative sentiment among investors, potentially impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
HC Wainwright & Co. slashed Terns Pharmaceuticals's price target from $11 to $8, maintaining a Neutral rating.
The price target cut by HC Wainwright & Co. could lead to a negative sentiment among investors, potentially impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Needham cut Viridian Therapeutics's price target from $47 to $40, maintaining a Buy rating.
The price target cut by Needham could lead to a negative sentiment among investors, potentially impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100